[Table/Fig-1]:
Groups | Total No. | Total Positive (Ki-67) | Total Positive (XIAP) |
---|---|---|---|
Benign | 40 | 16 (40%) | 04 (10%) |
Malignant | 50 | 24 (48%) | 13 (26%) |
Groups | Total No. | Total Positive (Ki-67) | Total Positive (XIAP) |
---|---|---|---|
Benign | 40 | 16 (40%) | 04 (10%) |
Malignant | 50 | 24 (48%) | 13 (26%) |